Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
NCT Number: NCT01188551
This is a study to compare intranasal dexmedetomidine to intranasal fentanyl following anesthesia induction in patients undergoing myringotomy and placement of pressure equalization (PE) tubes in providing analgesia and smoothing emergence from general anesthesia.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2 / Phase 3
Columbus, Ohio, 43205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
dexmedetomidine (1 µg/kg) will be administered intranasally
Other names: Precedex
fentanyl (2 µg/kg) will be administered intranasally
Sedative given pre-op.
Other names: Versed
Time frame: 30 mins. post-op
FLACC Behavioral Pain Assessment Scale: each of the five categories (F) Face, (L) Legs, (A) Activity, (C) Cry, (C) Consolability is scored from 0-2, which results in a total score between 0 and 10.
0 = Relaxed and comfortable 1-3 = Mild discomfort 4-6 = Moderate pain 7-10 = Severe discomfort or pain or both
Time frame: 30 mins. post-op
Post-anesthesia recovery score: Aldrete The Aldrete scoring system takes into account the patient's ability to move, respiration, circulation, consciousness, and oxygen saturation. A maximum of two points are awarded in each category and a score of 9 or 10 is required for discharge.
Nationwide Children's Hospital
Other
Pain Management Following Myringotomy and Tube Placement: Intranasal Dexmedetomidine Versus Fentanyl
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07595484
Chronic Otitis Media, Ear Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06398899
Chronic Otitis Media, Chronic Sinusitis
Taipei, Taiwan
View Trial DetailsNCT07149480
Chronic Otitis Media, Conductive Hearing Loss
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT04864912
Chronic Otitis Media
Le Kremlin-Bicêtre, France
View Trial Details